COVID-19 is associated with accelerated decline in kidney function, especially after hospitalization, according to a study.

The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.

Short sleep duration that persists during pregnancy and for 2 to 7 years after delivery is associated with increased odds of metabolic syndrome.

Hybrid closed loop technology was associated with superior efficacy and safety outcomes relative to standard insulin therapy in T1D.

There is a dose-dependent relationship between alcohol and sleep, especially for REM sleep onset latency and REM sleep duration.

The prevalence of idiopathic intracranial hypertension in US women varies geographically, some of which is explained by the varying prevalence of obesity.